» Articles » PMID: 22423261

Endoscopic Management of Nonampullary Duodenal Polyps

Overview
Publisher Sage Publications
Specialty Gastroenterology
Date 2012 Mar 17
PMID 22423261
Citations 22
Authors
Affiliations
Soon will be listed here.
Abstract

Duodenal polyps are a rare finding in patients presenting for gastroscopy, being found in 0.3-4.6% of cases. The majority of patients are asymptomatic. The most common lesions necessitating removal are duodenal adenomas which should be differentiated from other mucosal lesions such as ectopic gastric mucosa, and submucosal lesions such as carcinoids and gastrointestinal stromal tumours (GISTs). Adenomas can occur sporadically or as part of a polyposis syndrome. Both groups carry malignant potential but this is higher in patients with a polyposis syndrome. The majority of sporadic duodenal adenomas are flat or sessile and occur in the second part of the duodenum. Historically duodenal adenomas have been managed by radical surgery, which carried significant mortality and morbidity, or more conservative local surgical excision which resulted in high local recurrence rates. There is growing evidence for the use of endoscopic mucosal resection (EMR) techniques for treatment of sporadic nonampullary duodenal adenomas, with good outcomes and low complication rates. Endoscopic submucosal dissection (ESD) carries greater risk of complications and should be reserved for experts in this technique. Patients with sporadic duodenal adenomas carry an increased risk of colonic neoplasia and should be offered colonoscopy. The impact of endoscopic resection on the course of polyposis syndromes such as familial adenomatous polyposis (FAP) needs further study.

Citing Articles

Laparoscopic endoscopic cooperative surgery for the duodenal neuroendocrine tumor: a single-center case series (How I Do It).

Guo C, Ng H, Liu Y, Sun C, Zhang X, Zhao D Int J Surg. 2023; 109(7):1835-1841.

PMID: 37300883 PMC: 10389388. DOI: 10.1097/JS9.0000000000000440.


Histopathological spectrum of duodenal polyps in a retrospective ten-year study.

Rai V, Saha A, Verma R, Jain V, Baro B Discoveries (Craiova). 2022; 10(1):e143.

PMID: 36518221 PMC: 9742767. DOI: 10.15190/d.2022.2.


Molecular Aberrations in Periampullary Carcinoma.

Tewari M, Swain J, Dixit V, Shukla H Indian J Surg Oncol. 2022; 8(3):348-356.

PMID: 36118392 PMC: 9478047. DOI: 10.1007/s13193-017-0645-2.


A Rare Manifestation of a Bleeding Tubulovillous Duodenal Polyp Presenting as an Upper Gastrointestinal Hemorrhage.

Khalid Y, Dasu N, Suga H, Itidiare M, Walters R Case Rep Gastroenterol. 2020; 14(2):361-366.

PMID: 32884511 PMC: 7443676. DOI: 10.1159/000508436.


Pathologic Evaluation of Endoscopically Resected Non-Ampullary Duodenal Lesions: A Single Center Experience.

Taskin O, Aslan F, Mericoz C, Adsay V, Kapran Y Turk Patoloji Derg. 2019; 36(2):109-115.

PMID: 31825518 PMC: 10511249. DOI: 10.5146/tjpath.2019.01474.


References
1.
Jepsen J, Persson M, Jakobsen N, Christiansen T, Funch-Jensen P, Kruse A . Prospective study of prevalence and endoscopic and histopathologic characteristics of duodenal polyps in patients submitted to upper endoscopy. Scand J Gastroenterol. 1994; 29(6):483-7. DOI: 10.3109/00365529409092458. View

2.
Ahmad N, Kochman M, Long W, Furth E, Ginsberg G . Efficacy, safety, and clinical outcomes of endoscopic mucosal resection: a study of 101 cases. Gastrointest Endosc. 2002; 55(3):390-6. DOI: 10.1067/mge.2002.121881. View

3.
Takahashi T, Ando T, Kabeshima Y, Kawakubo H, Shito M, Sugiura H . Borderline cases between benignancy and malignancy of the duodenum diagnosed successfully by endoscopic submucosal dissection. Scand J Gastroenterol. 2009; 44(11):1377-83. DOI: 10.3109/00365520903287551. View

4.
Pequin P, Manfredi S, Quentin V, Heresbach D, Boyer J, Siproudhis L . Patients with sporadic duodenal adenoma are a high-risk group for advanced colorectal neoplasia: results of a case-control study. Aliment Pharmacol Ther. 2007; 26(2):277-82. DOI: 10.1111/j.1365-2036.2007.03359.x. View

5.
Gallagher M, Phillips R, Bulow S . Surveillance and management of upper gastrointestinal disease in Familial Adenomatous Polyposis. Fam Cancer. 2006; 5(3):263-73. DOI: 10.1007/s10689-005-5668-0. View